Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biological Psychiatry

• Publication date

  2012-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.biopsych.2012.03.029PMID 22521148PMCID PMC3408548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

  2012cited by this paper
• Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.

  2012cited by this paper
• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

  2012cited by this paper
• An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.

  2012cited by this paper
• Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

  2012cited by this paper
• Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

  2012cited by this paper
• Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

  2012cited by this paper
• Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.

  2011cited by this paper
• Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-d-Aspartate Antagonist

  2011cited by this paper
• NMDA Receptor Hypofunction Phase Couples Independent γ-Oscillations in the Rat Visual Cortex

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

  2011cited by this paper
• The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

  2011cited by this paper
• Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression

  2010cited by this paper
• Ketamine Modulates Theta and Gamma Oscillations

  2010cited by this paper
• Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

  2010cited by this paper
• Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine

  2010cited by this paper
• Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

  2010cited by this paper
• A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

  2010cited by this paper
• Abnormal neural oscillations and synchrony in schizophrenia

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• The Functional Consequences of Cortical Circuit Abnormalities on Gamma Oscillations in Schizophrenia: Insights from Computational Modeling

  2009cited by this paper
• Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

  2009cited by this paper
• Testing for a Cultural Influence on Reading for Meaning in the Developing Brain: The Neural Basis of Semantic Processing in Chinese Children

  2009cited by this paper
• Magnetoencephalographic gamma power reduction in patients with schizophrenia during resting condition

  2009cited by this paper
• Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

  2009cited by this paper
• Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

  2009cited by this paper
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

  2008cited by this paper
• N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.

  2008cited by this paper
• An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

  2008cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• Evoked amygdala responses to negative faces revealed by adaptive MEG beamformers.

  2008cited by this paper
• Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior.

  2007cited by this paper
• NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

  2007cited by this paper
• The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders

  2007cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity

  2006cited by this paper
• A direct demonstration of cortical LTP in humans: a combined TMS/EEG study.

  2006cited by this paper
• Increase in high frequency EEG activity explains the poor performance of EEG spectral entropy monitor during S-ketamine anesthesia.

  2006cited by this paper
• Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

  2005cited by this paper
• Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.

  2005cited by this paper
• An open-label trial of riluzole in patients with treatment-resistant major depression.

  2004cited by this paper
• Localization of event-related activity by SAM(erf).

  2004cited by this paper
• Localization of event-related activity by SAM(erf).

  2004cited by this paper
• Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV)

  2002cited by this paper
• Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate

  2002cited by this paper
• Regulation of AMPA receptors during synaptic plasticity.

  2002cited by this paper
• The Quantitative Evaluation of Functional Neuroimaging Experiments: Mutual Information Learning Curves

  2002cited by this paper
• The definition and meaning of treatment-resistant depression.

  2001cited by this paper
• Signal processing in magnetoencephalography.

  2001cited by this paper
• Reconstructing spatio-temporal activities of neural sources using an MEG vector beamformer technique

  2001cited by this paper
• Riluzole inhibits the persistent sodium current in mammalian CNS neurons

  2000cited by this paper
• Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

  1999cited by this paper
• Measurement of Dissociative States with the Clinician-Administered Dissociative States Scale (CADSS)

  1998cited by this paper
• Brief Psychological Intervention with Traumatized Young Women: The Efficacy of Eye Movement Desensitization and Reprocessing

  1998cited by this paper
• Single‐ and Multiple‐Dose Pharmacokinetics of Riluzole in White Subjects

  1997cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997cited by this paper
• AFNI: software for analysis and visualization of functional magnetic resonance neuroimages.

  1996cited by this paper
• Localization of the complex spectrum: the S transform

  1996cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• From Monoamine Deficits to Multiscale Plasticity: Twenty-Five Years of Ketamine and the Neurophysiology of Depression.

  2026cites this paper
• Sympathetic activation but not dissociation linked to ketamine's sustained antidepressant effect.

  2026cites this paper
• The Connectomic Glutamate Framework for Depression: Bridging Molecular Plasticity and Network Reorganization

  2025cites this paper
• Antidepressant-like effects of extinction learning as an animal model of behavioral therapy.

  2025cites this paper
• New advances in small molecule drugs targeting NMDA receptors

  2025cites this paper
• The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews

  2025cites this paper
• Ketamine-induced re-organisation of neural oscillations across health, MDD, and TRD: A systematic review of magnetoencephalography insights.

  2025cites this paper
• A Meta-Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder

  2025cites this paper
• Investigating acupuncture therapy in depression: mechanisms of synaptic plasticity regulation.

  2025cites this paper
• (2R,6R)‐hydroxynorketamine prevents opioid abstinence‐related negative affect and stress‐induced reinstatement in mice

  2025cites this paper
• Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions.

  2025cites this paper
• A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome

  2025cites this paper
• Anesthetics as Treatments for Depression: Clinical Insights and Underlying Mechanisms.

  2025cites this paper
• A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: Do the molecular and synaptic plasticity effects inform dosing intervals?

  2025cites this paper
• Efficacy and safety of perioperative application of esketamine on postpartum depression: A meta-analysis of randomized controlled studies.

  2024cites this paper
• Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.

  2024cites this paper
• Personalized use of ketamine and esketamine for treatment-resistant depression

  2024cites this paper
• Esketamine-Induced Dissociation: A Case Report

  2024influential citation
• Effects of Ketamine on Frontoparietal Interactions in a Rule-Based Antisaccade Task in Macaque Monkeys

  2024cites this paper
• Director's Message

  2024cites this paper
• PACAP/VIP Mediates the Rapid Antidepressant Effects of Zhizichi decoction.

  2024cites this paper
• Immediate and long-term electrophysiological biomarkers of antidepressant-like behavioral effects after subanesthetic ketamine and medial prefrontal cortex deep brain stimulation treatment

  2024cites this paper
• Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.

  2024cites this paper
• Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine

  2024cites this paper
• Ketamine potentiates a central glutamatergic presynapse

  2024cites this paper
• Sex differences in amygdalohippocampal oscillations and neuronal activation in a rodent anxiety model and in response to infralimbic deep brain stimulation

  2023cites this paper
• Mechanisms of Sustained Increases in γ Power Post-Ketamine in a Computational Model of the Hippocampal CA3: Implications for Ketamine’s Antidepressant Mechanism of Action

  2023cites this paper
• Storm on predictive brain: a neurocomputational account of ketamine antidepressant effect.

  2023cites this paper
• Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies.

  2023cites this paper
• Molecular mechanisms of rapid-acting antidepressants: new perspectives for developing antidepressants.

  2023cites this paper
• The effect of ketamine on synaptic mistuning induced by impaired glutamate reuptake

  2023cites this paper
• The contribution of gamma bursting to spontaneous gamma activity in schizophrenia

  2023cites this paper
• Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial

  2023cites this paper
• The Role of Psychotherapy in the Management of Treatment-Resistant Depression.

  2023cites this paper
• A Pain Physician and Anesthesiologist’s Perspective on Ketamine for Treatment-Resistant Depression

  2023cites this paper
• Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine

  2023cites this paper
• Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions

  2022cites this paper
• The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans

  2022cites this paper
• Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression.

  2022cites this paper
• Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis.

  2022cites this paper
• Is (R)-ketamine a Potential Therapeutic Agent for Treatment-Resistant Depression with Less Detrimental Side Effects? A Review of Molecular Mechanisms Underlying Ketamine and its Enantiomers.

  2022cites this paper
• Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

  2021cites this paper
• Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression

  2021cites this paper
• An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression

  2021cites this paper
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

  2021cites this paper
• Predictable Biomarkers for Rapid-Acting Antidepressant Response to Ketamine

  2021cites this paper
• S-Ketamine Exerts Antidepressant Effects by Regulating Rac1 GTPase Mediated Synaptic Plasticity in the Hippocampus of Stressed Rats

  2021cites this paper
• Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors

  2021cites this paper
• The Oscillatory Profile Induced by the Anxiogenic Drug FG-7142 in the Amygdala–Hippocampal Network Is Reversed by Infralimbic Deep Brain Stimulation: Relevance for Mood Disorders

  2021cites this paper
• Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology

  2021cites this paper
• Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression

  2021cites this paper
• Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression

  2021cites this paper
• Rapid‐acting antidepressants and the regulation of TrkB neurotrophic signalling—Insights from ketamine, nitrous oxide, seizures and anaesthesia

  2021cites this paper
• Imaging Genetic and Epigenetic Markers in Mood Disorders

  2021cites this paper
• Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder

  2021cites this paper
• Resting-State Functional Connectivity in Unipolar Depression

  2021cites this paper
• Effects of Lithium on Brain Structure in Bipolar Disorder

  2021cites this paper
• Magnetic Resonance Spectroscopy Investigations of Bioenergy and Mitochondrial Function in Mood Disorders

  2021cites this paper
• Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders

  2021cites this paper
• Functional Near-Infrared Spectroscopy Studies in Mood Disorders

  2021cites this paper
• Electrophysiological Biomarkers for Mood Disorders

  2021cites this paper
• fMRI Neurofeedback as Treatment for Depression

  2021cites this paper
• Functional Connectome in Bipolar Disorder

  2021cites this paper
• Brain Imaging of Reward Dysfunction in Unipolar and Bipolar Disorders

  2021cites this paper
• An Overview of Machine Learning Applications in Mood Disorders

  2021cites this paper
• Neuroimaging Biomarkers in Pediatric Mood Disorders

  2021cites this paper
• Neuroanatomical Findings in Bipolar Disorder

  2021cites this paper
• Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus

  2021cites this paper
• Brain Imaging Methods in Mood Disorders

  2021cites this paper
• Magnetoencephalography Studies in Mood Disorders

  2021cites this paper
• Neuroimaging Studies of Effects of Psychotherapy in Depression

  2021cites this paper
• Brain Imaging and the Mechanisms of Antidepressant Action

  2021cites this paper
• Neuroimaging Brain Inflammation in Mood Disorders

  2021cites this paper
• The Role of the Excitation:Inhibition Functional Balance in the mPFC in the Onset of Antidepressants.

  2021cites this paper
• Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression

  2021cites this paper
• Ketamine and attentional bias to threat: dynamic causal modeling of magnetoencephalographic connectivity in treatment-resistant depression

  2021influential citation
• Perisynaptic astrocytes as a potential target for novel antidepressant drugs.

  2021cites this paper
• Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms

  2021cites this paper
• Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

  2020cites this paper
• Ketamine Administration During Hospitalization Is Not Associated With Posttraumatic Stress Disorder Outcomes in Military Combat Casualties: A Matched Cohort Study

  2020cites this paper
• Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex

  2020cites this paper
• Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation.

  2020influential citation
• Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

  2020cites this paper
• Comparative Efficacy of Ketamine in Treatment-Resistant Depression

  2020cites this paper
• Transient dose-dependent effects of ketamine on neural oscillatory activity in Wistar-Kyoto rats.

  2020cites this paper
• Lack of antidepressant effects of burst-suppressing isoflurane anesthesia in adult male Wistar outbred rats subjected to chronic mild stress

  2020cites this paper
• Neurobiological biomarkers of response to ketamine.

  2020cites this paper
• Genome-wide association study and polygenic risk score analysis of esketamine treatment response

  2020cites this paper
• Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review

  2020cites this paper
• Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression

  2020cites this paper
• Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.

  2020cites this paper
• The time course of psychotic symptom side effects of ketamine in the treatment of depressive disorders: a systematic review and meta-analysis

  2020cites this paper
• Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.

  2020cites this paper
• Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

  2020cites this paper
• In Patients with Treatment-Resistant Depression, How Effective is Ketamine for Rapid Improvement of Depression and its Symptoms?

  2020cites this paper
• Studies on the developmental and antidepressant-like effects of anesthetics

  2020cites this paper
• The Substantiality of the Neuroplasticity Hypothesis of Major Depressive Disorder: The Prospective Use of Ketamine-Like Drugs as Antidepressants

  2020influential citation
• Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression

  2019cites this paper
• Magnetoencephalographic Correlates of Suicidal Ideation in Major Depression.

  2019cites this paper
• Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.

  2019influential citation